Category: neuroendocrine cancer

Richard R.P. Warner, MD2

Pancreatic Neuroendocrine Tumors: A Rare Cancer

August 26, 2011

From your next door neighbor to Steve Jobs, co-founder of Apple who just announced that he is stepping down as CEO of the company, pancreatic neuroendocrine tumors (pNETs) affect less than 1 person in 100,000 in the United States.  This rare cancer is often…

READ MORE
Steve Jobs Bloomberg News

Breaking News: Pancreatic NET Cancer Patient Steve Jobs Steps Down as CEO of Apple

August 24, 2011

On August 24, 2011, Steve Jobs, CEO of Apple, announced that he was stepping down from his position.  In his letter to the Apple Board of Directors and the Apple Community, Mr. Jobs wrote, “I have always said if there ever came a day when I could no longer meet…

READ MORE
Cranes

Two Lung Carcinoid Survivors Inspire and Lead the Way

August 17, 2011

Deirdre Durant finished folding the last of 1,000 origami cranes only days before surgery to remove her left lung.  She was seeking to fulfill the ancient Japanese legend that promises anyone who folds a thousand origami cranes will be granted a wish by…

READ MORE
CCAN logo

9 Conferences for the Carcinoid and Neuroendocrine Tumor Community

July 19, 2011

If you are a carcinoid or NET cancer survivor, caregiver, family member or medical professional you can learn about what’s happening now and what’s new in carcinoid/NETs treatments, clinical trials, research, and more from specialists…

READ MORE

Music for the Carcinoid and Neuroendocrine Tumor Community

June 30, 2011

What music has been important to you on your journey as a carcinoid neuroendocrine tumor survivor?  We asked this question on the Carcinoid Cancer Foundation’s Facebook page and got a wonderful variety of responses that we are sharing here with videos …

READ MORE

Carcinoid Cancer Foundation’s May 2011 Symposium Now Online

June 23, 2011

The Carcinoid Cancer Foundation is pleased to share with you videos from its carcinoid/NET symposium, “Neuroendocrine Tumor Management:  The Era of Personalized Medicine,” held on May 1, 2011 at Mt. Sinai Medical Center in New York City.

Following …

READ MORE
Peter Stothard

Worldwide NET Cancer Awareness Day Updates

June 21, 2011

With less than five months until the second Worldwide NET Cancer Awareness Day on Thursday, November 10, 2011, there have been many exciting developments to share with the carcinoid and NET community.

The first Chinese NET website (www.net.org.tw) …

READ MORE
Siemens’ Biograph mMR system

Up-to-the-Minute: News for the Carcinoid and Neuroendocrine Tumor Community

June 12, 2011

The first device that simultaneously performs PET and MRI scans, a new alpha-emitter-based therapy for NET cancer patients with progressive therapy-resistant tumors, the first–ever randomized virtual clinical trial, over 100  abstracts on carcinoid

READ MORE
Cancer.Net mobile

6 iPhone, Droid, BlackBerry, and iPad Apps for Carcinoid Patients and Physicians

May 30, 2011

A new iPhone app from ASCO, an app from 3M for physicians to help them manage and keep track of patient data, and the American Cancer Society’s Journals app are some of the newest mobile apps in the areas of medicine and healthcare.  For carcinoid and neuroendocrine

READ MORE
Multidisciplinary Team at Bad Berka

1st World Congress on Gallium-68 and Peptide Receptor Radionuclide Therapy (PRRNT)

April 5, 2011

Since 1997, when he first used the radiolabeled peptide Y-90 DOTATOC (a somatostatin analogue) to treat a 15-year-old boy with a rare neuroendocrine tumor, called paraganglioma, and saw the boy go from being wheelchair-bound and in terrible pain to …

READ MORE